Charles Schwab Corporation Cash, Cash Equivalents, and Marketable Securities decreased by 9.0% to $60.62B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 31.5%, from $88.50B to $60.62B. Over 4 years (FY 2020 to FY 2024), Cash, Cash Equivalents, and Marketable Securities shows an upward trend with a 2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial health, while lower levels may signal a need for external financing.
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term invest...
A standard liquidity metric reported by virtually all public companies on the balance sheet.
cash_equivalents_marketable_securities_total| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $166.95B | $202.99B | $256.35B | $236.19B | $259.48B | $236.15B | $147.24B | $141.08B | $125.52B | $110.26B | $105.53B | $99.77B | $93.28B | $88.50B | $81.49B | $72.56B | $66.64B | $60.62B |
| QoQ Change | — | +21.6% | +26.3% | -7.9% | +9.9% | -9.0% | -37.6% | -4.2% | -11.0% | -12.2% | -4.3% | -5.5% | -6.5% | -5.1% | -7.9% | -11.0% | -8.1% | -9.0% |
| YoY Change | — | — | — | — | +55.4% | +16.3% | -42.6% | -40.3% | -51.6% | -53.3% | -28.3% | -29.3% | -25.7% | -19.7% | -22.8% | -27.3% | -28.6% | -31.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.